Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Current Assets (2020 - 2025)

Historic Current Assets for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to $135.6 million.

  • P3 Health Partners' Current Assets fell 3693.72% to $135.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.6 million, marking a year-over-year decrease of 3693.72%. This contributed to the annual value of $184.1 million for FY2024, which is 1091.64% up from last year.
  • As of Q3 2025, P3 Health Partners' Current Assets stood at $135.6 million, which was down 3693.72% from $156.5 million recorded in Q2 2025.
  • P3 Health Partners' Current Assets' 5-year high stood at $242.1 million during Q2 2024, with a 5-year trough of $353250.0 in Q3 2021.
  • In the last 5 years, P3 Health Partners' Current Assets had a median value of $168.5 million in 2022 and averaged $146.2 million.
  • As far as peak fluctuations go, P3 Health Partners' Current Assets surged by 3505004.98% in 2022, and later crashed by 4874.61% in 2023.
  • P3 Health Partners' Current Assets (Quarter) stood at $353250.0 in 2021, then skyrocketed by 28404.46% to $100.7 million in 2022, then surged by 64.88% to $166.0 million in 2023, then increased by 10.92% to $184.1 million in 2024, then dropped by 26.34% to $135.6 million in 2025.
  • Its last three reported values are $135.6 million in Q3 2025, $156.5 million for Q2 2025, and $191.4 million during Q1 2025.